The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson ...
Medtronic (NYSE: MDT) announced today that it received new labeling approval from the FDA for its Endurant stent graft system.
Medtronic announced that the FDA has approved new labeling for the company’s Endurant stent graft system for use in the t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback